FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058842626> ?p ?o ?g. }

• W2058842626 endingPage "328" @default.
• W2058842626 startingPage "323" @default.
• W2058842626 abstract "Abstract Background The aim was to study the clinical efficacy and safety of rush oral immunotherapy (OIT) for severe peanut‐allergic children and to measure the antibody responses. Methods Eighteen Japanese children were enrolled after a positive double‐blind, placebo‐controlled food challenge (DBPCFC). The patients ingested peanuts up to 3–5 times a day every 30 min, increasing the dose by 20% every time. The goal dose was 3.5–7 g. IgE, IgG, and IgG4 antibody levels to peanut, and peanut allergen components were measured during up to 3 yr of maintenance treatment. Results Two children dropped out due to side effects. Sixteen patients (14 boys and two girls, median: 9 yr range: 5–14 yr) achieved the goal dose after a median of 11 days (range: 4–19 days). Their median threshold dose at DBPCFC was 0.20 g (range: 0.015–1.0 g). All were sensitized to Ara h 2. Fourteen of them had a history of previous anaphylaxis. In total, 173 adverse events were observed during the treatment (27% of the total ingestions) of which 74 needed medications. The median IgE, IgG, and IgG4 antibody levels to peanut increased during rush OIT. The IgG4 levels were high during the whole maintenance phase. IgE and IgG4 antibodies to Ara h 2 dominated the serological response during the treatment. Conclusions The present rush OIT protocol for children with severe peanut allergy was effective and relatively safe. A sustained Ara h 2‐specific IgG4 antibody response characterized the treatment." @default.
• W2058842626 created "2016-06-24" @default.
• W2058842626 creator A5008784133 @default.
• W2058842626 creator A5010068784 @default.
• W2058842626 creator A5019877696 @default.
• W2058842626 creator A5043227016 @default.
• W2058842626 creator A5086291598 @default.
• W2058842626 date "2014-06-01" @default.
• W2058842626 modified "2023-09-23" @default.
• W2058842626 title "Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy" @default.
• W2058842626 cites W1525297992 @default.
• W2058842626 cites W1994095603 @default.
• W2058842626 cites W1995091138 @default.
• W2058842626 cites W1998038810 @default.
• W2058842626 cites W2010233678 @default.
• W2058842626 cites W2012513978 @default.
• W2058842626 cites W2033385733 @default.
• W2058842626 cites W2055121714 @default.
• W2058842626 cites W2072646749 @default.
• W2058842626 cites W2084432817 @default.
• W2058842626 cites W2108175966 @default.
• W2058842626 cites W2128348634 @default.
• W2058842626 cites W2148903359 @default.
• W2058842626 cites W2172057771 @default.
• W2058842626 doi "https://doi.org/10.1111/pai.12243" @default.
• W2058842626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24953293" @default.
• W2058842626 hasPublicationYear "2014" @default.
• W2058842626 type Work @default.
• W2058842626 sameAs 2058842626 @default.
• W2058842626 citedByCount "35" @default.
• W2058842626 countsByYear W20588426262015 @default.
• W2058842626 countsByYear W20588426262016 @default.
• W2058842626 countsByYear W20588426262017 @default.
• W2058842626 countsByYear W20588426262018 @default.
• W2058842626 countsByYear W20588426262019 @default.
• W2058842626 countsByYear W20588426262020 @default.
• W2058842626 countsByYear W20588426262021 @default.
• W2058842626 countsByYear W20588426262022 @default.
• W2058842626 crossrefType "journal-article" @default.
• W2058842626 hasAuthorship W2058842626A5008784133 @default.
• W2058842626 hasAuthorship W2058842626A5010068784 @default.
• W2058842626 hasAuthorship W2058842626A5019877696 @default.
• W2058842626 hasAuthorship W2058842626A5043227016 @default.
• W2058842626 hasAuthorship W2058842626A5086291598 @default.
• W2058842626 hasConcept C126322002 @default.
• W2058842626 hasConcept C141105273 @default.
• W2058842626 hasConcept C142724271 @default.
• W2058842626 hasConcept C159654299 @default.
• W2058842626 hasConcept C197934379 @default.
• W2058842626 hasConcept C203014093 @default.
• W2058842626 hasConcept C204787440 @default.
• W2058842626 hasConcept C207480886 @default.
• W2058842626 hasConcept C27081682 @default.
• W2058842626 hasConcept C2775933838 @default.
• W2058842626 hasConcept C2776027960 @default.
• W2058842626 hasConcept C2776203516 @default.
• W2058842626 hasConcept C2777701055 @default.
• W2058842626 hasConcept C2778012357 @default.
• W2058842626 hasConcept C3018710434 @default.
• W2058842626 hasConcept C45189115 @default.
• W2058842626 hasConcept C71924100 @default.
• W2058842626 hasConcept C8891405 @default.
• W2058842626 hasConcept C90924648 @default.
• W2058842626 hasConceptScore W2058842626C126322002 @default.
• W2058842626 hasConceptScore W2058842626C141105273 @default.
• W2058842626 hasConceptScore W2058842626C142724271 @default.
• W2058842626 hasConceptScore W2058842626C159654299 @default.
• W2058842626 hasConceptScore W2058842626C197934379 @default.
• W2058842626 hasConceptScore W2058842626C203014093 @default.
• W2058842626 hasConceptScore W2058842626C204787440 @default.
• W2058842626 hasConceptScore W2058842626C207480886 @default.
• W2058842626 hasConceptScore W2058842626C27081682 @default.
• W2058842626 hasConceptScore W2058842626C2775933838 @default.
• W2058842626 hasConceptScore W2058842626C2776027960 @default.
• W2058842626 hasConceptScore W2058842626C2776203516 @default.
• W2058842626 hasConceptScore W2058842626C2777701055 @default.
• W2058842626 hasConceptScore W2058842626C2778012357 @default.
• W2058842626 hasConceptScore W2058842626C3018710434 @default.
• W2058842626 hasConceptScore W2058842626C45189115 @default.
• W2058842626 hasConceptScore W2058842626C71924100 @default.
• W2058842626 hasConceptScore W2058842626C8891405 @default.
• W2058842626 hasConceptScore W2058842626C90924648 @default.
• W2058842626 hasIssue "4" @default.
• W2058842626 hasLocation W20588426261 @default.
• W2058842626 hasLocation W20588426262 @default.
• W2058842626 hasOpenAccess W2058842626 @default.
• W2058842626 hasPrimaryLocation W20588426261 @default.
• W2058842626 hasRelatedWork W1982933711 @default.
• W2058842626 hasRelatedWork W2059846063 @default.
• W2058842626 hasRelatedWork W2127707303 @default.
• W2058842626 hasRelatedWork W2790166512 @default.
• W2058842626 hasRelatedWork W2810477128 @default.
• W2058842626 hasRelatedWork W2884220840 @default.
• W2058842626 hasRelatedWork W3008079180 @default.
• W2058842626 hasRelatedWork W3162023286 @default.
• W2058842626 hasRelatedWork W4323321738 @default.
• W2058842626 hasRelatedWork W4327951316 @default.
• W2058842626 hasVolume "25" @default.

• next